
1. j trop med hyg. 2013 jan;88(1):43-47. doi: 10.4269/ajtmh.2012.12-0364. epub
2012 nov 26.

characterization plasmodium falciparum sarcoplasmic/endoplasmic reticulum 
ca2+-atpase gene samples equatorial guinea implementation of
artemisinin-based combination therapy.

fernández-martínez a, mula p, cravo p, charle p, amor a, ncogo p, benito a,
berzosa p.

plasmodium falciparum resistance primary drugs used treatment of
malaria become main obstacle malaria control. artemisinin combination 
therapies current treatment strategy, suggested that
resistance artemisinin derivatives may related mutations the
plasmodium falciparum sarcoplasmic-endoplasmic reticulum ca(2+)-atpase ortholog
of mammalian sarco-endoplasmic reticulum ca(2+) atpase gene, known the
pfatp6 gene. thus, purpose study determine prevalence of
single-nucleotide polymorphisms (snps) pfatp6. presence different snps 
was detected polymerase chain reaction amplification pfatp6 gene, and
then sequencing identify possible alleles gene. total 20 snps 
were detected, including eight snps previously described:
k481r malabo; r801h annobon island; synonymous snps a141t, c1788t, 
a2211g, t2739g, a2760c, g2836a. genotypic profile pfatp6 samples
from equatorial guinea, may useful epidemiologic tool monitoring local
efficacy artemisinin combination therapies.

doi: 10.4269/ajtmh.2012.12-0364 
pmcid: pmc3541744
pmid: 23185077  [indexed medline]

